TipRanks

Meghan Fitzgerald Insider Profile

11 Followers
Meghan Fitzgerald, Director at Roivant Sciences, holds 41.16K shares in Roivant Sciences (Ticker: ROIV), holds 16.76K shares in Cardinal Health (Ticker: CAH), holds ― shares in Concert Pharma (Ticker: CNCE).
tipranks
Meghan Fitzgerald

Meghan Fitzgerald
Roivant Sciences (ROIV)
Director

Ranked #6,870 out of 109,106 Corporate Insiders

Profitable Transactions

33%
2 out of 6 Profitable Transactions

Average Return

+54.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
45.26%
38.19%
16.55%
A breakdown of Meghan Fitzgerald's holdings

Insider Roles

Tenet Healthcare
(THC)
Director
Cardinal Health
(CAH)
EVP, Strategy & Health Policy
Roivant Sciences
(ROIV)
Director
Roles that Meghan Fitzgerald holds in companies

Most Profitable Insider Trade

Stock:
Tenet Healthcare
(THC)
Rating:Informative Buy
Date:Mar 18, 2020 - Mar 18, 2021
Return:+383.00%
The most profitable trade made by Meghan Fitzgerald

Meghan Fitzgerald's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Roivant Sciences
Sep 18, 2026
Director
Uninformative Buy
$1.64M
Cardinal Health
Nov 17, 2015
EVP, Strategy & Health Policy
Uninformative Sell
22.41K
$3.78M
CNCE
Concert Pharma
Tenet Healthcare
May 26, 2026
Director
Uninformative Buy
231.65K
$4.48M
PEARQ
Pear Therapeutics
List of latest transactions for each holding click on a transaction to see Meghan Fitzgerald's performance on stock

Meghan Fitzgerald insider profile FAQ

What is the percentage of profitable transactions made by Meghan Fitzgerald?
The percentage of profitable transactions made by Meghan Fitzgerald is 33%.
    What is the average return per transaction made by Meghan Fitzgerald?
    The average return per transaction made by Meghan Fitzgerald is 54.70%.
      What stocks does Meghan Fitzgerald hold?
      Meghan Fitzgerald holds: ROIV, CAH, CNCE, THC, PEARQ stocks.
        What was Meghan Fitzgerald’s latest transaction?
        Meghan Fitzgerald latest transaction was an Uninformative Buy of ―.
          What was Meghan Fitzgerald's most profitable transaction?
          Meghan Fitzgerald’s most profitable transaction was an Informative Buy of THC stock on March 18, 2020. The return on the trade was 383.00%.
            What is Meghan Fitzgerald's role in Roivant Sciences?
            Meghan Fitzgerald's role in Roivant Sciences is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.